Merck & Co., Inc. Logo

Merck & Co., Inc.

A global biopharma developing innovative medicines, vaccines, and animal health products.

MRK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 EAST LINCOLN AVENUE, 7065 RAHWAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck & Co., Inc. is a global, research-intensive biopharmaceutical company dedicated to developing innovative health solutions. With a history spanning over 130 years, the company discovers, develops, manufactures, and markets a broad range of products, including prescription medicines, vaccines, biologic therapies, and animal health products. Merck focuses on scientific innovation to address significant global health challenges, leveraging a robust research pipeline and extensive clinical trials. The company is a leader in various therapeutic areas, particularly oncology and vaccines, aiming to save and improve lives worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 14:26
Declaration of Voting Results & Voting Rights Announcements
English 80.9 KB
2025-11-24 10:50
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-20 14:25
Declaration of Voting Results & Voting Rights Announcements
English 78.5 KB
2025-11-17 00:00
Regulatory Filings
Q3 statement / Q3 financial report 2025
English 489.3 KB
2025-10-24 15:20
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-23 17:37
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-21 09:10
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-17 18:51
Declaration of Voting Results & Voting Rights Announcements
English 78.0 KB
2025-10-16 09:03
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-10-14 08:31
Declaration of Voting Results & Voting Rights Announcements
English 77.8 KB
2025-09-01 00:00
Interim / Quarterly Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB

Automate Your Workflow. Get a real-time feed of all Merck & Co., Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Merck & Co., Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Merck & Co., Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom
HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom
HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea
376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland
HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
HERON THERAPEUTICS, INC. /DE/ Logo
Develops and commercializes therapies for acute care and oncology to manage pain and nausea.
United States of America
HRTX
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea
106190
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom
HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan
4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea
187420

Talk to a Data Expert

Have a question? We'll get back to you promptly.